MX2011007063A - Sintesis de estirilpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de los mismos. - Google Patents

Sintesis de estirilpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de los mismos.

Info

Publication number
MX2011007063A
MX2011007063A MX2011007063A MX2011007063A MX2011007063A MX 2011007063 A MX2011007063 A MX 2011007063A MX 2011007063 A MX2011007063 A MX 2011007063A MX 2011007063 A MX2011007063 A MX 2011007063A MX 2011007063 A MX2011007063 A MX 2011007063A
Authority
MX
Mexico
Prior art keywords
radiolabeled
pharmaceutical compositions
styrylpyridines
synthesis
stable pharmaceutical
Prior art date
Application number
MX2011007063A
Other languages
English (en)
Spanish (es)
Inventor
Wei Zhang
Tyler Benedum
Geoff Golding
Nathaniel Lim
Original Assignee
Avid Radiopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avid Radiopharmaceuticals Inc filed Critical Avid Radiopharmaceuticals Inc
Publication of MX2011007063A publication Critical patent/MX2011007063A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
MX2011007063A 2008-12-31 2009-12-29 Sintesis de estirilpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de los mismos. MX2011007063A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14188508P 2008-12-31 2008-12-31
PCT/US2009/069741 WO2010078370A1 (en) 2008-12-31 2009-12-29 Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
MX2011007063A true MX2011007063A (es) 2011-12-16

Family

ID=42310197

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011007063A MX2011007063A (es) 2008-12-31 2009-12-29 Sintesis de estirilpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de los mismos.

Country Status (35)

Country Link
US (1) US20100172836A1 (enExample)
EP (1) EP2381967B1 (enExample)
JP (1) JP5717650B2 (enExample)
KR (1) KR20110119670A (enExample)
CN (1) CN102271716B (enExample)
AU (1) AU2009335049B2 (enExample)
BR (1) BRPI0923890A2 (enExample)
CA (1) CA2748705C (enExample)
CO (1) CO6341578A2 (enExample)
CR (1) CR20110410A (enExample)
CY (1) CY1118658T1 (enExample)
DK (1) DK2381967T3 (enExample)
DO (1) DOP2011000210A (enExample)
EA (1) EA023014B1 (enExample)
EC (1) ECSP11011242A (enExample)
ES (1) ES2620402T3 (enExample)
HN (1) HN2011001810A (enExample)
HR (1) HRP20170453T1 (enExample)
HU (1) HUE033649T2 (enExample)
IL (1) IL213674A (enExample)
LT (1) LT2381967T (enExample)
MA (1) MA33004B1 (enExample)
MX (1) MX2011007063A (enExample)
MY (1) MY162312A (enExample)
NZ (1) NZ593848A (enExample)
PE (1) PE20120007A1 (enExample)
PL (1) PL2381967T3 (enExample)
PT (1) PT2381967T (enExample)
RS (1) RS55674B1 (enExample)
SG (1) SG172439A1 (enExample)
SI (1) SI2381967T1 (enExample)
TN (1) TN2011000318A1 (enExample)
UA (1) UA105914C2 (enExample)
WO (1) WO2010078370A1 (enExample)
ZA (1) ZA201104824B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9987379B2 (en) * 2008-09-30 2018-06-05 Case Western Reserve University Molecular probes for imaging of myelin
CN103269724B (zh) 2010-06-04 2017-06-23 皮拉马影像股份公司 生产F‑18标记的β‑淀粉样蛋白配体的方法
US20130217920A1 (en) * 2010-06-04 2013-08-22 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
TWI504414B (zh) * 2010-06-04 2015-10-21 Bayer Schering Pharma Ag 生產Ｆ－１８標記之Ａβ配位體之方法
KR20140012732A (ko) * 2011-04-21 2014-02-03 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 작용화된 자성 나노입자, 그리고 아밀로이드 침착물 및 신경섬유매듭의 영상화에서의 용도
SI2723394T1 (sl) * 2011-06-21 2018-10-30 Piramal Imaging Sa Formulacije fluoriranega stilbena, primerne za PET slikanje
IN2014MN00875A (enExample) 2011-10-19 2015-04-17 Piramal Imaging Sa
CN102432529B (zh) * 2011-11-14 2014-03-26 江苏省原子医学研究所 一种苯乙烯基吡啶二硫二氮衍生物的制备方法
CN104136420A (zh) * 2011-12-15 2014-11-05 通用电气健康护理有限公司 作为tau病理学的成像探针的杂环化合物
CN102526765B (zh) * 2011-12-31 2014-07-30 郑州泰基鸿诺药物科技有限公司 一种Aβ斑块显像剂及其制备方法
CN103965105A (zh) * 2013-01-29 2014-08-06 中山大学 苯乙烯基喹啉衍生物及其在治疗阿尔茨海默病症中的应用
CN103645254B (zh) * 2013-11-28 2015-01-07 江苏省原子医学研究所 一种Aβ斑块显像剂前体AV45的含量分析方法
WO2017014599A1 (ko) * 2015-07-22 2017-01-26 주식회사 씨코헬스케어 [18f]플루오로-도파의 방사화학적 순도를 안정화시키는 조성물 및 이의 제조방법
BR112018006969B1 (pt) * 2015-11-13 2022-04-26 Eli Lilly And Company Derivados de azetidina para formação de imagem de tau, seu intermediário, seu uso e seu processo de preparação, e composição
WO2017156303A1 (en) * 2016-03-09 2017-09-14 Case Western Reserve University Radioligands for myelin
CN107198780A (zh) * 2016-03-18 2017-09-26 南京江原安迪科正电子研究发展有限公司 放射性药物组合物及其制备方法、应用
CN106018575B (zh) * 2016-05-05 2018-10-19 江苏省原子医学研究所 一种PET显像剂前体TsOP-(+)-DTBZ及其光学异构体的分离测定方法
US10695450B2 (en) * 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
CN109922837A (zh) * 2016-11-08 2019-06-21 加利福尼亚大学董事会 用于临床应用的[f-18]fddnp的多剂量合成方法
TW201906818A (zh) * 2017-05-31 2019-02-16 美商５１１製藥公司 新穎氘取代之正子發射斷層掃描（ｐｅｔ）顯影劑及其藥理應用
WO2019145293A1 (en) * 2018-01-24 2019-08-01 Ac Immune Sa Diagnostic compositions for pet imaging, a method for manufacturing the diagnostic composition and its use in diagnostics
CN111499544B (zh) * 2019-01-31 2022-12-02 中国医学科学院放射医学研究所 一种一锅法制备N-Boc-N-甲基-4-氨基苯乙烯的合成方法
CN111499570B (zh) * 2019-01-31 2023-05-16 中国医学科学院放射医学研究所 一种av-45中间体的合成方法
US20220175973A1 (en) * 2019-03-29 2022-06-09 National Institutes for Quantum Science and Technology Method for producing radiopharmaceutical and radiopharmaceutical
CN115403434A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物的合成方法
CN115400232A (zh) * 2021-05-26 2022-11-29 汉中汉核医疗科技有限公司 一种放射性药物合成方法
CN113582885B (zh) * 2021-08-30 2023-04-21 南京克米斯璀新能源科技有限公司 一种烷基磺酸钠的生产方法
CN114805190A (zh) * 2022-06-08 2022-07-29 吉林大学第一医院 一种甲基苯胺类Aβ蛋白显像剂的双柱合成方法
AU2023381809A1 (en) * 2022-11-14 2025-05-22 Eli Lilly And Company Polymorphic forms of florbetapir precursor av-105
CN119080714A (zh) * 2024-09-12 2024-12-06 四川大学 一种偶氮苯磺酸酯化合物及其制备方法和应用、放射性探针的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067391A2 (en) * 2004-01-19 2005-07-28 Technion Research & Development Foundation Ltd. Diagnostic test for parkinson's disease
EP1838298A4 (en) * 2004-12-17 2009-03-04 Univ Pennsylvania STYLENE DERIVATIVES AND THEIR USE OF THE BINDING AND IMAGE DISPLAY OF AMYLOID PLAQUE
JP5290954B2 (ja) * 2006-03-30 2013-09-18 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア スチリルピリジン誘導体及びアミロイド斑を結合させ画像化するためのその使用

Also Published As

Publication number Publication date
PE20120007A1 (es) 2012-01-16
UA105914C2 (uk) 2014-07-10
HN2011001810A (es) 2013-08-12
CA2748705A1 (en) 2010-07-08
DOP2011000210A (es) 2011-09-15
JP2012514007A (ja) 2012-06-21
HUE033649T2 (en) 2017-12-28
EA023014B1 (ru) 2016-04-29
ECSP11011242A (es) 2011-10-31
IL213674A (en) 2016-04-21
CA2748705C (en) 2017-05-02
DK2381967T3 (en) 2017-03-27
RS55674B1 (sr) 2017-06-30
AU2009335049A1 (en) 2011-07-21
CY1118658T1 (el) 2017-07-12
BRPI0923890A2 (pt) 2015-07-28
CR20110410A (es) 2011-12-08
JP5717650B2 (ja) 2015-05-13
TN2011000318A1 (en) 2012-12-17
IL213674A0 (en) 2011-07-31
EP2381967B1 (en) 2017-01-18
NZ593848A (en) 2013-09-27
MY162312A (en) 2017-05-31
PT2381967T (pt) 2017-02-24
AU2009335049B2 (en) 2015-07-16
LT2381967T (lt) 2017-04-25
SI2381967T1 (sl) 2017-03-31
WO2010078370A1 (en) 2010-07-08
HRP20170453T1 (hr) 2017-06-02
US20100172836A1 (en) 2010-07-08
SG172439A1 (en) 2011-07-28
EP2381967A4 (en) 2013-01-02
EA201170911A1 (ru) 2011-12-30
KR20110119670A (ko) 2011-11-02
HK1162951A1 (en) 2012-09-07
EP2381967A1 (en) 2011-11-02
CN102271716B (zh) 2014-11-19
CO6341578A2 (es) 2011-11-21
CN102271716A (zh) 2011-12-07
ZA201104824B (en) 2013-01-30
MA33004B1 (fr) 2012-01-02
PL2381967T3 (pl) 2017-06-30
ES2620402T3 (es) 2017-06-28

Similar Documents

Publication Publication Date Title
TN2011000318A1 (en) Synthesis of 18f-radiolabeled strylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
MX2011011797A (es) Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
BRPI0908926A2 (pt) Compostos de policarbonato-poliorganosiloxano e/ou poliuretano-poliorganosiloxano
MX2010007587A (es) Compuestos que comprenden un grupo ciclobutoxi.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
MY148948A (en) Catecholamine derivatives and prodrugs thereof
WO2010055082A3 (en) New crystal form of sunitinib malate
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
WO2010068282A3 (en) Compositions and methods for synthesis of hydrogen fuel
WO2009115084A3 (de) Pyrrolopyrimidin-derivate und deren verwendungen
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
EP2129672A4 (en) ESTER AND CARBAMATE AZAADAMANTANE DERIVATIVES AND METHODS OF USE
MX2010010597A (es) Procesos para la preparacion de derivados de dioxina benzofusionados.
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
WO2009146202A3 (en) Transketalized compositions, synthesis, and applications
UA97965C2 (ru) Замещенные пиразолы, содержащая их композиция, способ их получения и применения
IN2011KN05169A (enExample)
WO2010077730A3 (en) Indanone inhibitors of acetylcholinesterase
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
ZA201303692B (en) Diphenyl-amine derivatives:uses,process of synthesis and pharmaceutical compositions
IL208580A0 (en) Novel compounds derived from taurine, process of their preparation and phamaceutoical compositions containing these

Legal Events

Date Code Title Description
FG Grant or registration